Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Participants were advised to fast before weighing
Phase 2 clinical trials published in the New England Journal of Medicine (2023) reported substantial reductions in body weight and improvements in glycaemic control in participants with obesity and type 2 diabetes, though these findings require confirmation in larger Phase 3 studies
Losing weight can lower pressure inside the abdomen and reduce overall inflammation, which may help protect against diverticular disease over time
Novo Nordisk also manufactures Wegovy
US$ 22.76
US$ 29.15
US$ 24.86
.png)
